Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Coccia-Portugal MA"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nuciforo P; Vall d'Hebron Institute of Oncology, Barcelona Spain. SOLTI, Barcelona, Spain. Electronic address: pnuciforo@vhio.net., Townend J; Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK., Piccart MJ; Institut Jules Bordet, Université Libre de Bruxelles (ULB) Brussels, Belgium., Fielding S; Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK., Gkolfi P; Global Drug Development, Novartis, Basel, Switzerland., El-Abed S; Breast International Group, Brussels, Belgium., de Azambuja E; Institut Jules Bordet, Université Libre de Bruxelles (ULB) Brussels, Belgium., Werutsky G; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil., Bliss J; The Institute of Cancer Research ICR-CTSU, London, UK., Moebus V; Dept. of Medicine II, Hematology & Oncology University of Frankfurt, Frankfurt, Germany., Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy., Aspitia AM; Jacoby Center for Breast Health, Mayo Clinic, Jacksonville, FL, USA., Gomez H; National Institute of Neoplastic Diseases Ricardo Palma University Lima, Peru., Gombos A; Institut Jules Bordet, Université Libre de Bruxelles (ULB) Brussels, Belgium., Coccia-Portugal MA; Coccia-Portugal M, Eastleigh Breast Care Centre, Pretoria, South Africa., Tseng LM; Taipei-Veterans General Hospital, National Yang Ming Chiao Tung University, Taipei, Taiwan., Kunz G; Dept. Obstet./Gyn., St.-Johannes-Hospital, Dortmund, Germany., Lerzo G; Fundación CENIT Para La Investigación Ciudad Autónoma de Buenos Aires, Argentina., Sohn J; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Semiglazov V; Breast Cancer Department, N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russian Federation., Saura C; Vall d'Hebron Institute of Oncology, Barcelona Spain. SOLTI, Barcelona, Spain., Kroep J; Department Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. Dutch Breast Cancer Oncology Group (BOOG), the Netherlands., Ferro A; Department of Medical Oncology, Rete Clinica Senologica- Santa Chiara Hospital, Trento, Italy., Cameron D; Edinburgh Cancer Research, The University of Edinburgh, Institute of Genetics and Cancer, Crewe Road South, Edinburgh, UK., Gelber R; Department of Data Science, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, Frontier Science Foundation, Boston, MA, USA., Huober J; Cantonal Hospital St.Gallen | Breast Center | St.Gallen, Switzerland. University of Ulm, Breast Center, Ulm, Germany., Di Cosimo S; Integrated Biology Platform, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Mar; Vol. 181, pp. 92-101. Date of Electronic Publication: 2022 Dec 27.
Autor:
Ligorio F; Metabolic Reprogramming in Solid Tumors Unit, IFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Di Cosimo S; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Verderio P; Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ciniselli CM; Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pizzamiglio S; Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Castagnoli L; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dugo M; Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy., Galbardi B; Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy., Salgado R; Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium.; Sir Peter MacCallum Cancer Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Loi S; Sir Peter MacCallum Cancer Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Michiels S; Department of Biostatistics and Epidemiology, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Triulzi T; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tagliabue E; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., El-Abed S; Breast International Group (BIG), Brussels, Belgium., Izquierdo M; Novartis Pharma AG, Basel, Switzerland., de Azambuja E; Department of Medical Oncology, Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B), Bruxelles, Belgium., Nuciforo P; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Huober J; Breast Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Moscetti L; Department of Oncology-Hematology, University Hospital of Modena, Modena, Italy.; Gruppo Oncologico Italiano per la Ricerca Clinica, Parma, Italy., Janni W; Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany., Coccia-Portugal MA; Clinical Trial Department, Eastleigh Breast Care Center, Pretoria, South Africa., Corsetto PA; Department of Pharmacology and Biomolecular Science, University of Milan, Milan, Italy., Belfiore A; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lorenzini D; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Daidone MG; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Vingiani A; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Oncology and Hemato-Oncology Department, University of Milan, Milan, Italy., Gianni L; Fondazione Michelangelo, Milan, Italy., Pupa SM; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bianchini G; Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy.; Breast Cancer Unit - Department of Medical Oncology, Università Vita-Salute San Raffaele, Milan, Italy., Pruneri G; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Oncology and Hemato-Oncology Department, University of Milan, Milan, Italy., Vernieri C; Metabolic Reprogramming in Solid Tumors Unit, IFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2022 Dec 08; Vol. 114 (12), pp. 1720-1727.
Autor:
Zhang QY; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Sun T; Department of Medical Oncology, Cancer Hospital of China Medical University/ Liaoning Cancer Hospital, Shenyang, China., Yin YM; Department of Oncology, Jiangsu Province Hospital, Nanjing, China., Li HP; Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China., Yan M; Department of Breast Disease, Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China., Tong ZS; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China., Oppermann CP; Centro de Pesquisa Clínica de Oncologia e Hematologia, Hospital Mãe de Deus/AESC, Porto Alegre, Brazil., Liu YP; Department of Medical Oncology, First Affiliated Hospital of China Medical University,Shenyang, China., Costa R; Oncologia Clínica, Instituto do Cancer do Estado de São Paulo - ICESP, São Paulo, Brazil., Li M; Department of Oncology, Second Affiliated Hospital of Dalian Medical University, Dalian, China., Cheng Y; Department of Medical Thoracic Oncology, Jilin Provincial Cancer Hospital, Changchun, China., Ouyang QC; Department of Breast Cancer Medical Oncology, Hunan Cancer Hospital, Changsha, China., Chen X; Department of Medical Oncology, Fuzhou General Hospital of Nanjing Military Command, Fuzhou, China., Liao N; Department of Breast Cancer, Guangdong General Hospital, Guangzhou, China., Wu XH; Department of Breast Cancer, Hubei Cancer Hospital, Wuhan, China., Wang XJ; Department of Breast Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China., Feng JF; Department of Medical Oncology, Jiangsu Province Cancer Hospital, Nanjing, China., Hegg R; Department of Gynecology and Obstetrics, Hospital Pérola Byington and FMUSP, São Paulo-SP, Brazil., Kanakasetty GB; Department of Medical Oncology, HCG Hospitals and Kidwai Memorial Institute of Oncology, Bangalore, India., Coccia-Portugal MA; Clinical Trial Department, Eastleigh Breast Care Center, Pretoria, South Africa., Han RB; Eli Lilly and Company, Shanghai, China., Lu Y; Eli Lilly and Company, Indianapolis, IN, United States of America., Chi HD; Eli Lilly and Company, Shanghai, China., Jiang ZF; Department of Breast Cancer, Fifth Medical Center of Chinese PLA General Hospital, 100 West Fourth Ring Middle Road, Beijing 100071, China., Hu XC; Department of Medical Oncology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai 200032, China.
Publikováno v:
Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2020 Oct 22; Vol. 12, pp. 1758835920963925. Date of Electronic Publication: 2020 Oct 22 (Print Publication: 2020).
Autor:
Fumagalli D; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Venet D; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Ignatiadis M; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Azim HA Jr; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Maetens M; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Rothé F; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Salgado R; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Bradbury I; Frontier Science Scotland, Kincraig, Inverness-shire, Scotland., Pusztai L; Breast Medical Oncology Section, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut., Harbeck N; Breast Center, Department of Obstetrics and Gynecology, University of Munich, Munich, Germany., Gomez H; Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru., Chang TW; Department of Surgery, National Cheng Kung University Hospital, Tainan, Taiwan., Coccia-Portugal MA; Clinical Trial Department, Eastleigh Breast Care Centre, Pretoria, South Africa., Di Cosimo S; Department of Oncology, Istituto Nazionale Tumori, Milan, Italy., de Azambuja E; Breast European Adjuvant Study Team, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., de la Peña L; SOLTI-Breast Cancer Research Group, Barcelona, Spain., Nuciforo P; Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Brase JC; Novartis Pharmaceutical, Basel, Switzerland., Huober J; Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany., Baselga J; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Piccart M; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Loi S; Division of Cancer Medicine and Research, Peter MacCallum Cancer Center, East Melbourne, Victoria, Australia., Sotiriou C; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium15Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Publikováno v:
JAMA oncology [JAMA Oncol] 2017 Feb 01; Vol. 3 (2), pp. 227-234.
Autor:
Gebhart G; Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Gámez C, Holmes E, Robles J, Garcia C, Cortés M, de Azambuja E, Fauria K, Van Dooren V, Aktan G, Coccia-Portugal MA, Kim SB, Vuylsteke P, Cure H, Eidtmann H, Baselga J, Piccart M, Flamen P, Di Cosimo S
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2013 Nov; Vol. 54 (11), pp. 1862-8. Date of Electronic Publication: 2013 Oct 03.
Publikováno v:
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde [S Afr Med J] 2003 Nov; Vol. 93 (11), pp. 804-5.
Autor:
Jacyk WK; Department of Dermatology, University of Pretoria, Republic of South Africa., Hazelhurst JA, Dreyer L, Coccia-Portugal MA
Publikováno v:
Clinical and experimental dermatology [Clin Exp Dermatol] 1993 Jan; Vol. 18 (1), pp. 89-91.
Publikováno v:
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde [S Afr Med J] 1992 Dec; Vol. 82 (6), pp. 480.
Autor:
Ansell SM; Department of Medical Oncology, University of Pretoria, Republic of South Africa., Rapoport BL, Coccia-Portugal MA, Stevens K, Bester CJ, Falkson G
Publikováno v:
Cancer genetics and cytogenetics [Cancer Genet Cytogenet] 1991 Feb; Vol. 51 (2), pp. 273-5.